MedTrace Logo

Erector Spinae Plane Block Versus Thoracic Epidural Analgesia in Patients With Multiple Fracture Ribs

NCT03853330 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2022-03-14

No results posted yet for this study

Summary

To assess the analgesic and respiratory effect of continuous Erector Spinae Plane block versus Thoracic Epidural in patients with multiple fracture ribs.

Conditions

  • Fracture; Rib, Multiple

Interventions

DEVICE

Ultrasound

Ultrasound-guided Thoracic Epidural Analgesia and Erector spinae plane block.

DRUG

Bupivacaine HCl Inj 0.25%

Bupivacaine HCl Inj 0.25% will be used in both blocks by the same dose of 7.5-12 ml

DRUG

Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution

infusion of Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution at 5-7 ml/h will be used in both blocks and also for breakthrough pain after both blocks as a bolus of 5-10 ml.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-12-01
Completion
2021-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853330 on ClinicalTrials.gov